This pathology video examines a challenging case of an epithelioid angiosarcoma, a highly malignant tumor filling the dermis that often mimics more common diagnoses like carcinoma or melanoma. The speaker highlights the critical histopathological feature for diagnosis: malignant epithelial cells wrapping and invading individual collagen bundles, often resulting in "floating" collagen bundles. Given the tumor's aggressive nature and high mortality rate, the video concludes with essential clinical management guidance, strongly recommending immediate referral to medical oncologists who specialize in treating angiosarcoma, such as Dr. Ravi (MD Anderson) or Dr. van Tine (Wash U).
A Challenging Case: Diagnosis and Management of Epithelioid Angiosarcoma
0:00 Initial Challenge: The case presents a malignant process in the dermis with round, epithelial-like cells, leading to an initial differential diagnosis including carcinoma or melanoma.
0:30 Definitive Diagnosis: The tumor is identified as an epithelioid angiosarcoma. This variant is noted for being cellular and closely mimicking carcinomas and melanomas, making diagnosis challenging.
0:40 Pathological Hallmark: The crucial diagnostic feature is the malignant epithelial cells completely wrapping and invading individual collagen bundles, resulting in "floating little collagen bundles." This anastomosing infiltration creates large channels, sometimes causing the epidermis to lift.
1:06 Diagnostic Strategy: It is essential to look for infiltrating vascular channels, often best seen at the periphery of the tumor, to confirm the diagnosis.
1:16 Key Takeaway (Immuno-stains): The speaker advises always including a vascular marker when assessing poorly differentiated spindle or epithelial tumors, especially in older, sun-damaged individuals.
1:22 Clinical Aggression: Angiosarcoma is an extremely aggressive tumor; quick and specialized treatment is necessary due to the high mortality rate.
1:27 Specialized Referral: Because angiosarcoma treatment differs significantly from that of regular sarcomas, the speaker advises sending patients to specialized medical oncologists: Dr. Ravi (MD Anderson) or Dr. van Tine (Wash U).